Answers are grounded in this paper and cite their sources.
Aim: Endometrial cancer evolves from a hyperestrogenic pattern.Bisphenol A (BPA) can act as estrogen-mimetic at low doses.The aim of this pilot observational case-control study is to evaluate the possible hormone-dependent effects of BPA in endometrial cancer.Methods: Biological samples from seventeen women affected by endometrial cancer and seven controls affected by benign uterine disease were collected.Two aliquots of 0.5mL or 25mg were taken from each blood, urine or tissue sample, one for total BPA measurement (free BPA plus BPA glucuronide and sulfate), and one for free BPA.Results: The concentration of BPA in blood and urine was higher in cases, while BPA concentration at uterine level was higher in controls.In the blood, higher BPA concentrations were found in cases compared to controls for free BPA (0.59±0.19 Vs 0.54±0.12),BPA conjugate (1.43±0.26Vs 0.94±0.18)and total BPA (2.01±0.31Vs 1.48±0.22),though not statistically significant.Similarly, in urine higher free BPA (2.00±0.84Vs 1.56±0.34,p<0.001), conjugated BPA (4.33±1.29 Vs 2.98±0.82,p<0.05) and total BPA (6.34±1.38Vs 4.54±0.65,p<0.01) concentrations were found in cases compared to controls.In uterine samples, free BPA, conjugated BPA and total BPA were lower in cases than controls (0.03±0.01 Vs 0.10±0.03,p<0.001; 0.06±0.01Vs 0.17±0.06,p<0.001 and 0.08±0.01Vs 0.26±0.08,p<0.001, respectively).Conclusion: Evaluating our results in the perspective of the literature, we hypothesized that BPA could induce an indirect abnormal cell proliferation at the uterine level.It probably acts as an hyperestrogenic central trigger, through a possible exacerbation of the action of the well-known risk factors .More studies are necessary to understand the mechanisms at the bases of the described process.
No takes yet. Share an insight, caveat, or question.
Laura Sarno (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: